Cargando…
Immune Checkpoint Blockade in Lung Carcinoids with Aggressive Behaviour: One More Arrow in Our Quiver?
Lung carcinoids are well-differentiated and low-/intermediate-grade neuroendocrine neoplasms of the lung. Given their relative rarity, and the paucity of data available from prospective studies, no global consensus exists on the systemic treatment of these tumours. In recent years, immune checkpoint...
Autores principales: | Di Molfetta, Sergio, Feola, Tiziana, Fanciulli, Giuseppe, Florio, Tullio, Colao, Annamaria, Faggiano, Antongiulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876213/ https://www.ncbi.nlm.nih.gov/pubmed/35207291 http://dx.doi.org/10.3390/jcm11041019 |
Ejemplares similares
-
Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
por: Di Molfetta, Sergio, et al.
Publicado: (2021) -
Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks
por: Fanciulli, Giuseppe, et al.
Publicado: (2020) -
Commentary: Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management
por: Fanciulli, Giuseppe, et al.
Publicado: (2021) -
New Evidence on Carbetocin: Another Arrow in Our Quiver
por: Hodgins, Steve
Publicado: (2018) -
Commentary: Bioprosthetic pulmonary valve endocarditis: Another “arrow in our quiver”
por: Ali-Ghosh, Hani, et al.
Publicado: (2021)